| |
Thursday, October 16 |
| 12:00 |
Registration |
|
| |
|
|
| Session 1 |
Cord blood transplant: banking, organization, regulatory issues – Chair: TBA |
|
| 14.00-14.15 |
Netcord organization |
J. Garcia (Barcelona) |
| 14.15-14.30 |
Challenges in the international exchange of CBUs |
M. Boo (Minneapolis) |
| 14.30-14.45 |
Biological resource center |
P. Rebulla (Milan) |
| 14.45-15.00 |
Report from Asia Cord |
S. Kato (Tokyo) |
| 15.00-15.15 |
Latin America |
E. Calderon (Mexico City) |
| 15.15-15.30 |
London cord blood bank |
C. Navarrete (London) |
| 15.30 - 16.00 |
Coffee-Break |
|
| 16.00-16.30 |
Sibling cord blood banking |
B. Lubin (Oakland) |
| 16.30-17.00 |
The unrealized potential of umbilical cord blood units for unrelated donor hematopoietic cell transplantation |
L. Petz (Arcadia) |
| 17.00-17.45 |
Debate: Is there a place for autologous cord blood banking? |
L. Petz (Arcadia)
C. Camby (Paris)
G. Garrido (Madrid)
Y. Beguin (Liège) |
| 18.00 |
Opening Ceremony Celebration Cord Blood Transplant History
|
|
| |
Guest of Honour: José Carreras
|
|
| |
Special Guests: H. Broxmeyer, A. Auerbach, P. Rubinstein, J. Wagner, P. Wernet,
M. Benbunan, E. Gluckman,
G. Sirchia, M. Contreras, J.J. Van Rood, J. Kurtzberg and Patients
|
|
| |
Birthday Party with music and dance |
|
| |
Friday, October 17 |
| Session 2 |
Stem cells from cord blood – Chair: TBA |
|
| 9.00-9.30 |
Cord blood-derived very small embryonic like (VSEL) stem cells |
M. Ratajczak (Louisville) |
| 9.30-10.00 |
Biology of cord blood stem cells |
P. Simmons (Houston) |
| 10.00-10.30 |
Functional characterization of stem cell subpopulations in cord blood |
G. Kögler (Düsseldorf) |
| 10.30-11.00 |
Coffee-Break |
|
| 11.00-11.30 |
Embryonic like cells from umbilical cord blood |
C. McGuckin (Newcastle) |
| 11.30-12.00 |
The umbilical cord as a stem cell source: cells derived from Wharton's Jelly |
M.L. Weiss (Manhatten) |
| 12.00-12.30 |
Notch signalling in haematopoietic stem cell differentiation: implications for cord blood transplantation |
I. Bernstein (Seattle) |
| 12.30-13.00 |
Title to be defined |
W. Fibbe (Leiden) |
| 13.00-14.00 |
Buffet lunch and poster viewing |
|
| Session 3 |
Cord Non hematopoietic stem cells – Chair: TBA |
|
| 14.00-14.30 |
Re-defining human circulating endothelial progenitor cells |
M.C. Yoder (Indianapolis) |
| 14.30-15.00 |
Early foetal MSC and maternal and foetal tissue repair |
N.M. Fisk (Brisbane) |
| 15.00-15.30 |
Cord non hematopoietic stem cells |
P. Wernet (Düsseldorf) |
| 15.30-16.00 |
Hepatic and non hematopoietic progenitors |
J. Nolta (Sacremento) |
| 16.00-16.30 |
Cord blood to treat neurological diseases |
J. Kurtzberg (Durham) |
| 16.30-17.00 |
Coffee-break and poster viewing |
|
| 17.00-17.30 |
Isolation and characterization of cells from human term placenta |
O. Parolini (Brescia) |
| 17.30-18.00 |
Stem cell mobilization by beta2-agonists |
J.A. Cancelas (Cincinnati) |
| 18.00-18.30 |
Biology of stem/progenitor cell production and process development |
F. Godia (Barcelona) |
| |
Saturday, October 18 |
| Session 4 |
Immunological properties – Chair: TBA |
|
| 8.00-8.30 |
Umbilical cord blood-derived T cells expressing chimeric antigen receptor to target B-cell malignancies |
P. Dotti (Houston) |
| 8.30-9.00 |
Immune properties of cord blood |
F. Falkengurg (Leiden) |
| 9.00-9.30 |
Virus specific cord blood T cells for clinical use |
C. Bollard (Houston) |
| 9.30-10.00 |
Natural killer cells in cord blood and stem cell transplantation |
R. Champlin (Houston) |
| 10.00-10.30 |
Coffee-Break |
|
| Session 5 |
Role of HLA in cord blood transplant – Chair: TBA |
|
| 10.30-11.00 |
Influence of KIR mismatching in the outcome of cord blood transplant |
R. Willemze (Leiden) |
| 11.00-11.30 |
Role of HLA and cell dose in cord blood transplant |
P. Rubinstein (New York) |
| 11.30-12.30 |
Panel discussion on donor choice |
J. Wagner (Minneapolis)
P. Rubinstein (New York)
E. Gluckman (Paris)
M. Horowitz (Milwaukee) |
| 12.30-13.00 |
Cord Blood or non T-cell depleted Haploidentical Transplant for patients with hematological malignancies |
W. Arceze (Rome) |
| 13.00 - 14.00 |
Lunch |
|
| Session 6 |
New protocols for cord blood transplant |
|
| 14.00-14.30 |
Double cord blood transplant |
J. Wagner (Minneapolis) |
| 14.30-15.00 |
Reduce intensity conditioning |
J. Barker (New York) |
| 15.00-15.30 |
Direct intra-bone (IBM) transplant of cord blood cells |
F. Frassoni (Genoa) |
| Session 7 |
Cord blood transplant in children |
|
| 15.30-16.00 |
Leukaemia |
F. Locatelli (Pavia) |
| 16.00-16.30 |
Haemoglobinopathies |
M. Walters (Oakland) |
| 16.30-17.00 |
Coffee-Break |
|
| 17.00-18.30 |
Selected abstracts and poster presentation |
|
| |
Sunday, October 19 |
| Session 8 |
Graft facilitation - Homing – Chair: TBA |
|
| 8.30-9.00 |
Mechanistic insights into engraftment |
H.E. Broxmeyer (Indianapolis) |
| 9.00-9.30 |
Regulation of stem cell homing, retention and mobilization |
T. Lapidot (Rehovot) |
| 9.30-10.00 |
Stem cells and their niche: a leverage point for therapy |
D. Scadden (Boston) |
| 10.00-10.30 |
Methods for promoting engraftment |
E.J. Shpall (Houston) |
| 10.30-11.00 |
Coffee-Break |
|
| Session 9 |
Clinical results of cord blood transplant Eurocord Studies |
|
| 11.00-11.30 |
Acute Leukaemia |
V. Rocha (Paris) |
| 11.30-12.00 |
Lymphoma |
C.A. Rodrigues (São Paulo) |
| 12.00-12.30 |
Hurler |
J. Boelens (Ultrech) |
| |
End of the meeting |
|
| |
|
|
| |
|
*pending confirmation |